Caroline Alkner is the Head of In Vitro at Redoxis AB. With a strong background in molecular biology and immunology, she joined Redoxis in 2012 and has been a key contributor to building and advancing the company’s in vitro service platform.
Caroline leads the development and execution of Redoxis’ in vitro assays, including flow cytometry, ELISA, Luminex, and primary cell–based assays. She is responsible for team coordination, technical development, and ensuring the generation of high-quality, reproducible data that support robust preclinical research.
With a dedicated focus on assay robustness, scientific relevance, and continuous improvement, Caroline ensures that Redoxis’ in vitro services meet the evolving needs of clients working in inflammation, autoimmunity, and complex immunological mechanisms.
